These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12397561)

  • 21. What is the appropriate approach to prevention of thromboembolism in heart failure?
    Freudenberger RS; Schumaecker MM; Homma S
    Thromb Haemost; 2010 Mar; 103(3):489-95. PubMed ID: 20024492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation in patients with atrial fibrillation and congestive heart failure.
    Veloso HH; de Paola AA
    Am J Cardiol; 2005 Jun; 95(12):1533. PubMed ID: 15950594
    [No Abstract]   [Full Text] [Related]  

  • 23. Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone system.
    Bauersachs J; Schäfer A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):889-93. PubMed ID: 15521482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thromboembolic risk in chronic cardiac insufficiency].
    Tavazzi L
    Rev Port Cardiol; 1997 Sep; 16(9):723-4. PubMed ID: 9409939
    [No Abstract]   [Full Text] [Related]  

  • 25. Huff and Puff, This CASTLE Is Made of Bricks.
    Marrouche NF; Kheirkhahan M; Brachmann J
    Circulation; 2018 Aug; 138(8):754-755. PubMed ID: 29848751
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative use of levosimendan in two patients with severe aortic stenosis and left ventricular dysfunction.
    Prior DL; Flaim BD; MacIsaac AI; Yii MY
    Heart Lung Circ; 2006 Feb; 15(1):56-8. PubMed ID: 16473793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of patients hospitalized for heart failure with abnormal versus normal left ventricular ejection fraction.
    Sule S; Aronow WS
    Compr Ther; 2009; 35(1):50-4. PubMed ID: 19351105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.
    Das SR; Drazner MH; Yancy CW; Stevenson LW; Gersh BJ; Dries DL
    Am Heart J; 2004 Nov; 148(5):883-8. PubMed ID: 15523322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rationale for the use of anticoagulation in heart failure management.
    Pulerwitz T; Rabbani LE; Pinney SP
    J Thromb Thrombolysis; 2004 Apr; 17(2):87-93. PubMed ID: 15306743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diastolic dysfunction and diastolic heart failure].
    Rossi G
    Recenti Prog Med; 2007; 98(7-8):407-16. PubMed ID: 17685191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aspirin, oral anticoagulants, and heart failure].
    Gibelin P
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1377-81. PubMed ID: 9864607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
    Fortuna P; Reis I; Ascenção R; Carneiro AV
    Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anticoagulant therapy in left ventricular non-compaction: when, how and why].
    Costantino J; Maria Ajmone F; Maggio E; Ballatore F; Manguso G; Ciaramella P; Galea N; Alfarano M; Severino P; Lavalle C; Vizza CD; Chimenti C
    G Ital Cardiol (Rome); 2023 Nov; 24(11):866-871. PubMed ID: 37901977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diastolic dysfunction as a risk factor in patients with heart failure].
    Nessler J; Skrzypek A; Piwowarska W
    Przegl Lek; 2004; 61(9):962-7. PubMed ID: 15803909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of withdrawing chronic anticoagulation without antithrombotic prophylaxis.
    Kadayifci A; Haznedaroglu IC; Savas MC
    Am J Gastroenterol; 1997 Feb; 92(2):361-2. PubMed ID: 9040230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.